NEW YORK (GenomeWeb) – B Braun Medical US and Tuebingen, Germany-based CeGaT today announced the launch of a US company offering next-generation sequencing-based diagnostics.

The new firm called B Braun CeGaT is based in B Braun Medical's headquarters in Bethlehem, Pa. and will offer CeGaT's diagnostic panels for evaluating all the genes that are associated with a patient's phenotype. The technology was launched in 2010 and is being made available in the US with the establishment of B Braun CeGaT.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

CNBC reports that Amazon invested in the startup Grail as it sees an opportunity for its cloud computing company in genomics.

Lawrence Krauss writes at Slate that science is needed for good public policy and should not be ignored.

Researchers are working on re-making the yeast genome from scratch, according to the Associated Press.

In Cell this week: functional profiling of Plasmodium genome, a self-inactivating rabies virus, and more.